GENEVA, June 26 -- DAIICHI SANKYO COMPANY, LIMITED filed a patent application (IB2025/062383) for “AN ANTIBODY-DRUG CONJUGATE FOR USE IN THE TREATMENT OF DRUG-RESISTANT CANCER”. With publication no. WO/2026/120507, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 47/68
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....